Invasive vs. Conservative Management of NSTEMI in Patients Aged 75+ Years

1017374 patient records from 5 randomized controlled trials and 22 observational studies were aggregated to assess treatment outcomes for older patients with non-ST-segment elevation myocardial infarction. The dataset, associated with research from the Chinese Academy of Medical Sciences & Peking Union Medical College, includes meta-analysis results on all-cause death, myocardial infarction, stroke, and major bleeding. Pooled odds ratios and confidence intervals are provided for comparing invasive and conservative management strategies.

Use Cases

• Compare mortality and adverse event risks between treatment strategies based on the reported odds ratios.
• Analyze the association between invasive management and major bleeding risk in patients aged 85+ years.
• Validate meta-analysis and trial sequential analysis (TSA) methodologies using the aggregated study results.
• Investigate real-world versus clinical trial outcomes for NSTEMI management as suggested by the description.

Strengths

• Aggregates data from 27 studies involving over 1 million patients, providing a substantial evidence base.
• Includes results from both randomized controlled trials and observational studies with multivariable adjustment.
• Reports specific statistical measures including pooled odds ratios, confidence intervals, and I² heterogeneity statistics.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the underlying patient-level data is unknown, which may limit suitability assessment.
• Last update date is unknown; freshness unverified.

Provenance

Source

paperswithcode, associated with author Mengjin Hu from Chinese Academy of Medical Sciences & Peking Union Medical College.

Collection Method

Meta-analysis and trial sequential analysis of relevant randomized controlled trials and observational studies.